Effectiveness of the CoronaVac vaccine in the elderly population during a P.1 variant-associated epidemic of COVID-19 in Brazil: A test-negative case-control study
Otavio T. Ranzani, Matt Hitchings, Murilo Dorion Nieto, Tatiana Lang D’Agostini, Regiane Cardoso de Paula, Olivia Ferreira Pereira de Paula, Edlaine Faria de Moura Villela, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, View ORCID ProfileWade Schulz, Maria Almiron, Rodrigo Said, Roberto Dias de Oliveira, Patricia Vieira da Silva, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
doi: https://doi.org/10.1101/2021.05.19.21257472
Otavio T. Ranzani
1Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
2Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
Matt Hitchings
3Department of Biology, University of Florida, Gainesville, FL, USA
4Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Murilo Dorion Nieto
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Tatiana Lang D’Agostini
6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil
Regiane Cardoso de Paula
6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil
Olivia Ferreira Pereira de Paula
6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil
Edlaine Faria de Moura Villela
6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil
Mario Sergio Scaramuzzini Torres
7Municipal Health Secretary of Manaus, Brazil, AM, Brazil
Silvano Barbosa de Oliveira
8Pan American Health Organization, Brasília, DF, Brazil
9Universidade de Brasília, Brasília, DF, Brazil
Wade Schulz
10Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
Maria Almiron
8Pan American Health Organization, Brasília, DF, Brazil
Rodrigo Said
8Pan American Health Organization, Brasília, DF, Brazil
Roberto Dias de Oliveira
11State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil
Patricia Vieira da Silva
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
Wildo Navegantes de Araújo
8Pan American Health Organization, Brasília, DF, Brazil
9Universidade de Brasília, Brasília, DF, Brazil
13National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil
Jason R. Andrews
14Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
Derek A.T. Cummings
3Department of Biology, University of Florida, Gainesville, FL, USA
4Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Albert I. Ko
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
15Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil
Julio Croda
5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
16Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 21, 2021.
Effectiveness of the CoronaVac vaccine in the elderly population during a P.1 variant-associated epidemic of COVID-19 in Brazil: A test-negative case-control study
Otavio T. Ranzani, Matt Hitchings, Murilo Dorion Nieto, Tatiana Lang D’Agostini, Regiane Cardoso de Paula, Olivia Ferreira Pereira de Paula, Edlaine Faria de Moura Villela, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Wade Schulz, Maria Almiron, Rodrigo Said, Roberto Dias de Oliveira, Patricia Vieira da Silva, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.05.19.21257472; doi: https://doi.org/10.1101/2021.05.19.21257472
Effectiveness of the CoronaVac vaccine in the elderly population during a P.1 variant-associated epidemic of COVID-19 in Brazil: A test-negative case-control study
Otavio T. Ranzani, Matt Hitchings, Murilo Dorion Nieto, Tatiana Lang D’Agostini, Regiane Cardoso de Paula, Olivia Ferreira Pereira de Paula, Edlaine Faria de Moura Villela, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Wade Schulz, Maria Almiron, Rodrigo Said, Roberto Dias de Oliveira, Patricia Vieira da Silva, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.05.19.21257472; doi: https://doi.org/10.1101/2021.05.19.21257472
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12176)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3834)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)